Constipation in Children With Neurofibromatosis Type 1

被引:8
|
作者
Pedersen, Cecilie E. [1 ]
Krogh, Klaus [2 ]
Siggaard, Charlotte
Joensson, Iben M.
Haagerup, Annette [1 ]
机构
[1] Aarhus Univ Hosp, Dept Paediat, Ctr Rare Dis, DK-8000 Aarhus N, Denmark
[2] Aarhus Univ Hosp, Dept Gastroenterol & Hepatol, Neurogastroenterol Unit, DK-8000 Aarhus N, Denmark
关键词
child; colonic transit time; constipation; neurofibromatosis type 1; ultrasonography; COLONIC TRANSIT; DIAGNOSTIC-TOOL; ULTRASOUND; ADULTS; RECTUM;
D O I
10.1097/MPG.0b013e31826ad7e0
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background and Objectives: Neurofibromatosis type 1 (NF1) is a hereditary, heterogenic, and multiorganic disease. The NF1 phenotype shows great variability in expressivity and often includes symptoms from the central and peripheral nervous systems. Bowel symptoms have been reported, but gastrointestinal function in NF1 remains to be described in detail. In this first systematic study of bowel function in children with NF1, we aimed to investigate symptoms of constipation and test the hypotheses that children with NF1 have abnormally large rectum and prolonged colonic transit time (CTT). Methods: A total of 20 children with NF1 (age 8.2 +/- 2.4 years) were evaluated with medical history; clinical examination; digital rectal examination; bowel and dietary diaries; Rome III criteria; measurement of rectal diameter by transabdominal ultrasound; and radiographic estimation of CTT. The control group for assessment of rectal diameter comprised 23 healthy children (mean age 9.1 +/- 2.7 years). Results: A total of 6 children with NF1 (30%) were constipated according to Rome III criteria. Average rectal diameter was significantly larger than for healthy children (32.9 +/- 7.2 mm vs 21.4 +/- 5.9 mm, P < 0.0001). Median CTT in NF1 children was 53 hours (range 26-101). Compared with existing normative data, CTT was prolonged (>84 hours) in 3 (19%). Conclusions: Symptoms of constipation were surprisingly common in children with NF1. Correspondingly, rectal diameters were abnormally large and a higher proportion than expected had prolonged CTT. The underlying pathophysiology remains obscure, but we hypothesise that abnormalities of the enteric nervous system or disturbed cellular growth could be present.
引用
收藏
页码:229 / 232
页数:4
相关论文
共 50 条
  • [21] A New Treatment for Children With Neurofibromatosis Type 1
    Voelker, Rebecca
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2020, 323 (19): : 1887 - 1887
  • [22] Health Supervision for Children With Neurofibromatosis Type 1
    Miller, David T.
    Freedenberg, Debra
    Schorry, Elizabeth
    Ullrich, Nicole J.
    Viskochil, David
    Korf, Bruce R.
    Chen, Emily
    Trotter, Tracy L.
    Berry, Susan A.
    Burke, Leah W.
    Geleske, Timothy A.
    Hamid, Rizwan
    Hopkin, Robert J.
    Introne, Wendy J.
    Lyons, Michael J.
    Scheuerle, Angela E.
    Stoler, Joan M.
    Freedenberg, Debra
    Jones, Marilyn C.
    [J]. PEDIATRICS, 2019, 143 (05)
  • [23] Ophthalmological assessment of children with neurofibromatosis type 1
    Cassiman, Catherine
    Legius, Eric
    Spileers, Werner
    Casteels, Ingele
    [J]. EUROPEAN JOURNAL OF PEDIATRICS, 2013, 172 (10) : 1327 - 1333
  • [24] NEUROIMAGING IN CHILDREN WITH NEUROFIBROMATOSIS TYPE-1
    KORF, BR
    [J]. JOURNAL OF PEDIATRICS, 1993, 122 (05): : 834 - 834
  • [25] Renal manifestations in children with neurofibromatosis type 1
    Celik, Binnaz
    Aksoy, Ozlem Yuksel
    Bastug, Funda
    Poyrazoglu, Hatice Gamze
    [J]. EUROPEAN JOURNAL OF PEDIATRICS, 2021, 180 (12) : 3477 - 3482
  • [26] Muscle weakness in children with neurofibromatosis type 1
    Cornett, Kayla M. D.
    North, Kathryn N.
    Rose, Kristy J.
    Burns, Joshua
    [J]. DEVELOPMENTAL MEDICINE AND CHILD NEUROLOGY, 2015, 57 (08): : 733 - 736
  • [27] Attention Skills in Children With Neurofibromatosis Type 1
    Isenberg, Jill C.
    Templer, Alexandra
    Gao, Feng
    Titus, Jeffrey B.
    Gutmann, David H.
    [J]. JOURNAL OF CHILD NEUROLOGY, 2013, 28 (01) : 45 - 49
  • [28] Cerebral Vasculopathy in Children with Neurofibromatosis Type 1
    Lehman, Laura L.
    Ullrich, Nicole J.
    [J]. CANCERS, 2023, 15 (20)
  • [29] Developmental Delays in Children With Neurofibromatosis Type 1
    Soucy, Elizabeth A.
    Gao, Feng
    Gutmann, David H.
    Dunn, Courtney M.
    [J]. JOURNAL OF CHILD NEUROLOGY, 2012, 27 (05) : 641 - 644
  • [30] Ophthalmological assessment of children with neurofibromatosis type 1
    Catherine Cassiman
    Eric Legius
    Werner Spileers
    Ingele Casteels
    [J]. European Journal of Pediatrics, 2013, 172 : 1327 - 1333